Endometriosis Market Report 2026

Endometriosis Market Overview

• Endometriosis market size has reached to $1.54 billion in 2025 • Expected to grow to $2.44 billion in 2030 at a compound annual growth rate (CAGR) of 9.8% • Growth Driver: Elevated Ovarian Cancer Incidence Fuels Growth In The Endometriosis Market • Market Trend: Innovative Blood-Based Test Enables Early Detection Of A Chronic Gynecological Conditioncare • North America was the largest region in 2025.

What Is Covered Under Endometriosis Market?

Endometriosis is a chronic medical condition that occurs when tissue similar to the lining of the uterus (endometrium) grows outside the uterus. The condition can cause severe pain in the pelvis and make it harder to get pregnant. It can significantly impact a person's quality of life and fertility. The main types of endometriosis are superficial peritoneal lesions, endometrioma, deeply infiltrating endometriosis and others. A superficial peritoneal lesion refers to a specific type of abnormal tissue growth that occurs in cases of endometriosis. It includes various treatments, such as hormonal therapy and pain management. These diseases can be treated by various drugs, such as oral contraceptives, progestins, nonsteroidal anti-inflammatory drugs (NSAIDs), GnRH analogs, levonorgestrel-releasing intrauterine devices (LNR-IUDs) and others used by different end-users such as hospitals, homecare, specialty centers and others.

What Is The Endometriosis Market Growth Forecast?

The endometriosis market size is expected to see strong growth in the next few years. It will grow to $2.44 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to early screening initiatives, improved diagnostic accuracy, personalized treatment approaches, women’s health advocacy, expansion of specialty care. Major trends in the forecast period include rising awareness of chronic pelvic pain, increased diagnosis of fertility-related disorders, growing use of hormonal therapies, expansion of specialty gynecology centers, focus on long-term disease management.

Global Endometriosis Market Segmentation

1) By Type: Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating Endometriosis, Other Types 2) By Treatment Type: Hormonal Therapy, Pain Management 3) By Drug: Oral Contraceptives, Progestins, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Gonadotropin Releasing Hormone (GnRH) Analogues, Levonorgestrel-Releasing Intrauterine Devices (LNR-IUDs), Other Drugs 4) By End-User: Hospitals, Homecare, Specialty Centers, Other End-Users Subsegments: 1) By Superficial Peritoneal Lesion: Minimal Lesions, Mild Lesions, Peritoneal Surface Lesions 2) By Endometrioma: Ovarian Endometrioma, Chocolate Cyst, Bilateral Endometrioma 3) By Deeply Infiltrating Endometriosis: Rectovaginal Deep Lesions, Bladder Deep Lesions, Ureteral Deep Lesions 4) By Other Types: Adenomyosis-Associated Endometriosis, Extraperitoneal Endometriosis, Rare Anatomical Site Endometriosis

What Is The Driver Of The Endometriosis Market?

The increasing incidence of ovarian cancer is expected to propel the growth of the endometriosis market going forward. Ovarian cancer is a type of cancer that begins in the ovaries, the female reproductive organs responsible for producing eggs and the hormones estrogen and progesterone. Endometriosis is associated with an increased risk of developing epithelial ovarian cancer, mainly the endometrioid and precise cell cancer subtypes, characterized by high estrogen concentrations, which can increase the risk of developing ovarian cancer. For instance, in January 2023, according to the American Cancer Society, a US-based professional organization, it is projected that approximately 19,710 new cases of ovarian cancer will be diagnosed among women in the US in 2023. Furthermore, in 2022, according to the Ovarian Cancer Research Alliance, a US-based not-for-profit organization, ovarian cancer caused 12,810 deaths in 2022 and increased to 13,270 fatalities in 2023. Therefore, the increasing incidence of ovarian cancer is driving the growth of the endometriosis industry.

Key Players In The Global Endometriosis Market

Major companies operating in the endometriosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck and Co. Inc., Abbvie Inc., Bayer AG, GlaxoSmithKline plc, Abbott Laboratories, Eli Lilly and Company, Mylan N.V., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, Cadila Pharmaceuticals Ltd., Gedeon Richter plc, Torrent Pharmaceuticals Ltd., Ferring Pharmaceuticals, Kissei Pharmaceutical Co. Ltd., Sanofi India Ltd., Repros Therapeutics Inc., Myovant Sciences Ltd., Takeda Pharmaceutical Company Limited, ObsEva SA, Gesynta Pharma AB, Zydus Healthcare Limited

Global Endometriosis Market Trends and Insights

Major companies in the endometriosis market are developing innovative solutions, including non-invasive diagnostic assays, to improve early detection and patient management. Non-invasive diagnostic assays are tests that detect or monitor a disease without requiring surgery or inserting instruments into the body, often using blood, urine, saliva, or imaging. For instance, in July 2025, Kephera Diagnostics LLC, a US‑based diagnostic laboratory, launched EndomTest, an innovative blood‑based diagnostic test for endometriosis. EndomTest is a laboratory‑developed test that analyzes a patient’s serum sample for the biomarkers Brain‑Derived Neurotrophic Factor (BDNF) and Cancer Antigen 125 (CA125), then combines those biomarker results with selected clinical variables using a proprietary diagnostic algorithm to generate a positive or negative “rule‑in” indication for endometriosis. Its unique features include a non‑surgical sampling method (just a blood draw), high specificity (reported at nearly 100%) for identifying the disease, and clinical applications that span women presenting with pelvic pain, heavy menstrual bleeding, infertility, or pain with sexual intercourse.

What Are Latest Mergers And Acquisitions In The Endometriosis Market?

In January 2024, Hera Biotech Inc., a US-based women’s-health diagnostics company acquired endometriosis diagnostic assets and associated intellectual property of Scailyte,for an undisclosed amount. With this acquisition Hera Biotech aims to accelerate the development of its next-generation endometriosis diagnostic by integrating Scailyte’s single-cell data analytics and biomarker-discovery platform. Scailyte AG is a Switzerland-based biotechnology company specializing in AI-driven single-cell analysis for precision diagnostics.

Regional Outlook

North America was the largest region in the endometriosis market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Endometriosis Market?

The endometriosis market consists of revenues earned by entities by providing services such as laparoscopy, nutritional counseling, physical therapy, diagnostic laparoscopy, fertility treatment, surgical interventions and complementary therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The endometriosis market also includes sales of birth control pills, patches and vaginal rings. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Endometriosis Market Report 2026?

The endometriosis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the endometriosis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.